273 related articles for article (PubMed ID: 16115924)
1. New monoclonal antibodies to mesothelin useful for immunohistochemistry, fluorescence-activated cell sorting, Western blotting, and ELISA.
Onda M; Willingham M; Nagata S; Bera TK; Beers R; Ho M; Hassan R; Kreitman RJ; Pastan I
Clin Cancer Res; 2005 Aug; 11(16):5840-6. PubMed ID: 16115924
[TBL] [Abstract][Full Text] [Related]
2. Establishment of novel mAb to human ERC/mesothelin useful for study and diagnosis of ERC/mesothelin-expressing cancers.
Ishikawa K; Segawa T; Hagiwara Y; Maeda M; Abe M; Hino O
Pathol Int; 2009 Mar; 59(3):161-6. PubMed ID: 19261093
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-32 monoclonal antibodies for immunohistochemistry, Western blotting, and ELISA.
Kim KH; Shim JH; Seo EH; Cho MC; Kang JW; Kim SH; Yu DY; Song EY; Lee HG; Sohn JH; Kim J; Dinarello CA; Yoon DY
J Immunol Methods; 2008 Apr; 333(1-2):38-50. PubMed ID: 18252253
[TBL] [Abstract][Full Text] [Related]
4. Megakaryocyte potentiation factor cleaved from mesothelin precursor is a useful tumor marker in the serum of patients with mesothelioma.
Onda M; Nagata S; Ho M; Bera TK; Hassan R; Alexander RH; Pastan I
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4225-31. PubMed ID: 16857795
[TBL] [Abstract][Full Text] [Related]
5. Diffuse mesothelin expression correlates with prolonged patient survival in ovarian serous carcinoma.
Yen MJ; Hsu CY; Mao TL; Wu TC; Roden R; Wang TL; Shih IeM
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):827-31. PubMed ID: 16467095
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic activity of the recombinant anti-mesothelin immunotoxin, SS1(dsFv)PE38, towards tumor cell lines established from ascites of patients with peritoneal mesotheliomas.
Li Q; Verschraegen CF; Mendoza J; Hassan R
Anticancer Res; 2004; 24(3a):1327-35. PubMed ID: 15274292
[TBL] [Abstract][Full Text] [Related]
7. Production and characterization of monoclonal antibodies against vaginolysin: mapping of a region critical for its cytolytic activity.
Zvirbliene A; Pleckaityte M; Lasickiene R; Kucinskaite-Kodze I; Zvirblis G
Toxicon; 2010 Aug; 56(1):19-28. PubMed ID: 20298711
[TBL] [Abstract][Full Text] [Related]
8. Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients.
Ho M; Hassan R; Zhang J; Wang QC; Onda M; Bera T; Pastan I
Clin Cancer Res; 2005 May; 11(10):3814-20. PubMed ID: 15897581
[TBL] [Abstract][Full Text] [Related]
9. Sensitive and specific new enzyme-linked immunosorbent assay for N-ERC/mesothelin increases its potential as a useful serum tumor marker for mesothelioma.
Shiomi K; Hagiwara Y; Sonoue K; Segawa T; Miyashita K; Maeda M; Izumi H; Masuda K; Hirabayashi M; Moroboshi T; Yoshiyama T; Ishida A; Natori Y; Inoue A; Kobayashi M; Sakao Y; Miyamoto H; Takahashi K; Hino O
Clin Cancer Res; 2008 Mar; 14(5):1431-7. PubMed ID: 18316566
[TBL] [Abstract][Full Text] [Related]
10. A DNA vaccine encoding a single-chain trimer of HLA-A2 linked to human mesothelin peptide generates anti-tumor effects against human mesothelin-expressing tumors.
Hung CF; Calizo R; Tsai YC; He L; Wu TC
Vaccine; 2007 Jan; 25(1):127-35. PubMed ID: 16930783
[TBL] [Abstract][Full Text] [Related]
11. Production and characterization of monoclonal antibodies against shope fibroma virus superoxide dismutase and glutathione-s-transferase.
Shahhosseini S; Guttikonda S; Bhatnagar P; Suresh MR
J Pharm Pharm Sci; 2006; 9(2):165-8. PubMed ID: 16959186
[TBL] [Abstract][Full Text] [Related]
12. New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope.
Key G; Becker MH; Baron B; Duchrow M; Schlüter C; Flad HD; Gerdes J
Lab Invest; 1993 Jun; 68(6):629-36. PubMed ID: 7685843
[TBL] [Abstract][Full Text] [Related]
13. A novel high-affinity human monoclonal antibody to mesothelin.
Ho M; Feng M; Fisher RJ; Rader C; Pastan I
Int J Cancer; 2011 May; 128(9):2020-30. PubMed ID: 20635390
[TBL] [Abstract][Full Text] [Related]
14. Heterologous immunization, a way out of the problem of monoclonal antibody production against carcinoma antigen 125.
Shojaeian S; Zarnani AH; Jeddi-Tehrani M; Fereidooni F; Torkabadi E; Akhondi MM; Tabatabaei-Panah AS; Allameh A
Iran J Immunol; 2009 Dec; 6(4):174-85. PubMed ID: 20054105
[TBL] [Abstract][Full Text] [Related]
15. [The preparation and identification on monoclonal antibody to platelet-derived growth factor receptor].
Wang ZD; Fang L; Wei DP; Zhang CJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 38(3):504-8. PubMed ID: 17593843
[TBL] [Abstract][Full Text] [Related]
16. [Preparation and characterization of monoclonal antibodies against human CD112 (Nectin2/PRR2)].
Deng HP; Zhuang R; Song CJ; Tian Y; Jia W; Zhang Y; Jin BQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Apr; 23(4):356-8. PubMed ID: 17428395
[TBL] [Abstract][Full Text] [Related]
17. Carcinoembryonic antigen-immunoglobulin Fc fusion protein (CEA-Fc) for identification and activation of anti-CEA immunoglobulin-T-cell receptor-modified T cells, representative of a new class of Ig fusion proteins.
Ma Q; DeMarte L; Wang Y; Stanners CP; Junghans RP
Cancer Gene Ther; 2004 Apr; 11(4):297-306. PubMed ID: 15002034
[TBL] [Abstract][Full Text] [Related]
18. Mesothelin: a new target for immunotherapy.
Hassan R; Bera T; Pastan I
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3937-42. PubMed ID: 15217923
[TBL] [Abstract][Full Text] [Related]
19. [Preparation and characterization of the monoclonal antibody against human soluble mesothelin-related proteins].
Chen SC; Liu YK; Wu XH; Shan BE; Chen X; Sun DX; Wang L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Mar; 23(3):246-8. PubMed ID: 17343793
[TBL] [Abstract][Full Text] [Related]
20. Secretion of N-ERC/mesothelin and expression of C-ERC/mesothelin in human pancreatic ductal carcinoma.
Inami K; Kajino K; Abe M; Hagiwara Y; Maeda M; Suyama M; Watanabe S; Hino O
Oncol Rep; 2008 Dec; 20(6):1375-80. PubMed ID: 19020717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
